Search research articles
Contact Us
Filters
Showing results (41-50 of 76) with videos related to
Page
of 8
Sort By:
Research and Practice in Thrombosis and Haemostasis
|
February 24, 2025
Recombinant factor VIIa: new insights into the mechanism of action through product innovation
Miguel A Escobar, Maureane Hoffman, Giancarlo Castaman, et al.
Stem Cell Research
|
April 12, 2017
Generation of human iPSCs from urine derived cells of patient with a novel heterozygous PAI-1 mutation
Muhammad Zeeshan Afzal, Melanie Gartz, Ekaterina A Klyachko, et al.
Blood
|
January 12, 2018
Plasminogen replacement therapy for the treatment of children and adults with congenital plasminogen deficiency
Amy D Shapiro, Charles Nakar, Joseph M Parker, et al.
Haemophilia : the Official Journal of the World Federation of Hemophilia
|
May 23, 2019
Factor VIII prophylaxis effects outweigh other hemostasis contributors in predicting severe haemophilia A joint outcomes
Beth Boulden Warren, Linda Jacobson, Christine Kempton, et al.
Transfusion
|
March 16, 2002
Pharmacokinetic analysis of plasma-derived and recombinant F IX concentrates in previously treated patients with moderate or severe hemophilia B
Bruce M Ewenstein, J Heinrich Joist, Amy D Shapiro, et al.
Patient Preference and Adherence
|
October 17, 2017
Reliability of patient-reported outcome instruments in US adults with hemophilia: the Pain, Functional Impairment and Quality of life (P-FiQ) study
Christine L Kempton, Michael Wang, Michael Recht, et al.
Haemophilia : the Official Journal of the World Federation of Hemophilia
|
August 31, 2019
Thrombin and plasmin generation in patients with plasminogen or plasminogen activator inhibitor type 1 deficiency
Joline L Saes, Saskia E M Schols, Kathleen F Betbadal, et al.
Blood
|
December 11, 2012
The polygenic nature of inhibitors in hemophilia A: results from the Hemophilia Inhibitor Genetics Study (HIGS) Combined Cohort
Jan Astermark, Sharyne M Donfield, Edward D Gomperts, et al.
Circulation
|
June 8, 2017
Plasminogen Activator Inhibitor Type I Controls Cardiomyocyte Transforming Growth Factor-β and Cardiac Fibrosis
Panagiotis Flevaris, Sadiya S Khan, Mesut Eren, et al.
The New England Journal of Medicine
|
September 9, 2020
BIVV001 Fusion Protein as Factor VIII Replacement Therapy for Hemophilia A
Barbara A Konkle, Amy D Shapiro, Doris V Quon, et al.
Page
of 8
Search research articles
Search
Showing results (41-50 of 76) with videos related to
Sort By:
Page
of 8
Research and Practice in Thrombosis and Haemostasis
|
February 24, 2025
Recombinant factor VIIa: new insights into the mechanism of action through product innovation
Miguel A Escobar, Maureane Hoffman, Giancarlo Castaman, et al.
Stem Cell Research
|
April 12, 2017
Generation of human iPSCs from urine derived cells of patient with a novel heterozygous PAI-1 mutation
Muhammad Zeeshan Afzal, Melanie Gartz, Ekaterina A Klyachko, et al.
Blood
|
January 12, 2018
Plasminogen replacement therapy for the treatment of children and adults with congenital plasminogen deficiency
Amy D Shapiro, Charles Nakar, Joseph M Parker, et al.
Haemophilia : the Official Journal of the World Federation of Hemophilia
|
May 23, 2019
Factor VIII prophylaxis effects outweigh other hemostasis contributors in predicting severe haemophilia A joint outcomes
Beth Boulden Warren, Linda Jacobson, Christine Kempton, et al.
Transfusion
|
March 16, 2002
Pharmacokinetic analysis of plasma-derived and recombinant F IX concentrates in previously treated patients with moderate or severe hemophilia B
Bruce M Ewenstein, J Heinrich Joist, Amy D Shapiro, et al.
Patient Preference and Adherence
|
October 17, 2017
Reliability of patient-reported outcome instruments in US adults with hemophilia: the Pain, Functional Impairment and Quality of life (P-FiQ) study
Christine L Kempton, Michael Wang, Michael Recht, et al.
Haemophilia : the Official Journal of the World Federation of Hemophilia
|
August 31, 2019
Thrombin and plasmin generation in patients with plasminogen or plasminogen activator inhibitor type 1 deficiency
Joline L Saes, Saskia E M Schols, Kathleen F Betbadal, et al.
Blood
|
December 11, 2012
The polygenic nature of inhibitors in hemophilia A: results from the Hemophilia Inhibitor Genetics Study (HIGS) Combined Cohort
Jan Astermark, Sharyne M Donfield, Edward D Gomperts, et al.
Circulation
|
June 8, 2017
Plasminogen Activator Inhibitor Type I Controls Cardiomyocyte Transforming Growth Factor-β and Cardiac Fibrosis
Panagiotis Flevaris, Sadiya S Khan, Mesut Eren, et al.
The New England Journal of Medicine
|
September 9, 2020
BIVV001 Fusion Protein as Factor VIII Replacement Therapy for Hemophilia A
Barbara A Konkle, Amy D Shapiro, Doris V Quon, et al.
Page
of 8